Vancouver BC / TheNewswire / June 3, 2019 - Izotropic Corporation. (the Company) announces that it has granted a total of 300,000 stock options, 100,000 to an officer and 200,000 to a consultant of the Company. These Options have an exercise price of $0.30 per share, vest immediately and may be exercised for a period of 2 years from the date of grant.

 

On behalf of the Board.

R.L. Thast, CEO

   

About Izotropic Corp.

The Company is engaged in the development and commercialization of next-generation, 3-D breast CT imaging technology for early diagnosis of breast cancer, that improves patient comfort, provides a true 360-degree-view acquisition and delivers high diagnostic accuracy.

The Company has also established a wholly owned U.S subsidiary called Isotropic Imaging Corp in 2016 to advance the company’s breast imaging development.

Phone: 1-833-IZOCORP
Email: info@izocorp.com
Website: www.izocorp.com